Literature DB >> 17314928

World Health Organization program for the selection and use of essential medicines.

M M Reidenberg1.   

Abstract

The WHO program on essential medicines advises governments about how to determine which medicines are needed to meet the health care needs of the majority of the population and how to make them available to everyone. A Model List of these medicines proposed in 1977 included 186 drugs; the current list exceeds 300. The principle of making essential medicines available to everyone is accepted by 156 countries. Implementation is variable. Problems currently being considered for solution include whether drugs effective for rare diseases are ever essential and getting pediatric dosage forms of essential drugs manufactured and registered for sale. With all societies dealing with the rising cost of medical care and having to make choices, the concept of essential medicines is a relevant to all now as it was to countries with limited resources when the WHO program started in 1975.

Mesh:

Year:  2007        PMID: 17314928     DOI: 10.1038/sj.clpt.6100106

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  7 in total

1.  Technology in global health: the need for essential diagnostics.

Authors:  Eric R Houpt; Richard L Guerrant
Journal:  Lancet       Date:  2008-09-13       Impact factor: 79.321

2.  Inhibition of Plasmodium sporozoites infection by targeting the host cell.

Authors:  Ricardo Leitao; Ana Rodriguez
Journal:  Exp Parasitol       Date:  2010-05-21       Impact factor: 2.011

3.  WHO Essential Medicines List for Children: impact on patient outcomes?

Authors:  Andy Gray
Journal:  Paediatr Drugs       Date:  2011-08-01       Impact factor: 3.022

4.  Development of one paediatric and one neonatal formulary list in hospital settings.

Authors:  Sissel Sundell Haslund-Krog; Hanne Rolighed Christensen; Mia Bjerager; Helle Holst
Journal:  Br J Clin Pharmacol       Date:  2017-11-03       Impact factor: 4.335

5.  A need for the standardization of the pharmaceutical sector in Libya.

Authors:  Asma Abubakr Mustafa; Stefan Robert Kowalski
Journal:  Libyan J Med       Date:  2010-10-21       Impact factor: 1.657

6.  WHO and national lists of essential medicines in Mexico, Central and South America, and the Caribbean: are they adequate to promote paediatric endocrinology and diabetes care?

Authors:  Amanda Rowlands; Alejandra Acosta-Gualandri; Jaime Guevara-Aguirre; Jean-Pierre Chanoine
Journal:  BMJ Glob Health       Date:  2016-10-27

7.  Accessibility and use of essential medicines in health care: Current progress and challenges in India.

Authors:  Dipika Bansal; Vilok K Purohit
Journal:  J Pharmacol Pharmacother       Date:  2013-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.